Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea Final LCD - Effective March 15, 2020
This Local Coverage Determination (LCD) has completed the Open Public Meeting and Contractor Advisory Committee (CAC) comment period and is now finalized under contractor numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY). Responses to comments received may be found as a link at the bottom of the final LCD.
Medicare Coverage Database (MCD) Number/Contractor Determination Number: L38312
LCD Title: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
Effective Date: March 15, 2020
Summary of LCD: This LCD provides coverage for FDA-approved hypoglossal nerve neurostimulation for the treatment of moderate to severe obstructive sleep apnea under specified criteria.
Visit the Future LCDs webpage to access this LCD.
Last Updated Jan 30, 2020